NCT06852443 (TD-CHAT) is a NA clinical trial of Selfhelp modules in Prevention, sponsored by Charite University, Berlin, Germany.

Who is sponsoring NCT06852443?

NCT06852443 is sponsored by Charite University, Berlin, Germany.

What drugs are being tested in NCT06852443?

Interventions in NCT06852443: Selfhelp modules, Therapist Chat Service.

What condition does NCT06852443 study?

NCT06852443 studies Prevention, Well Being, Sexual Behavior, Behavior Change, Behavior Problems, Behavior Change Interventions, Child Sexual Abuse Material (CSAM) Consumption, Behavioral Disorder, Online Behaviour.

Is NCT06852443 still recruiting?

NCT06852443 is currently recruiting now. Last updated 7 May 2025.

Last reviewed 2025-05-07 · How we verify

NCT06852443: TD-CHAT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT)

Recruiting now NA Last updated 7 May 2025

What this trial tests

NA trial testing Selfhelp modules in Prevention in 180 participants. Currently enrolling.

Timeline

1 April 2025

Primary endpoint
28 February 2026

31 July 2026

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	180
Start date	1 April 2025
Primary completion	28 February 2026
Estimated completion	31 July 2026
Sites	2 locations across Germany, Spain

Drugs / interventions tested

Selfhelp modules
Therapist Chat Service

Conditions studied

Prevention — all drugs for Prevention →
Well Being — all drugs for Well Being →
Sexual Behavior — all drugs for Sexual Behavior →
Behavior Change — all drugs for Behavior Change →

Sponsor

Charite University, Berlin, Germany

Who can join

Adults 18 to 99, any sex, with Prevention or Well Being. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective multicentred, stratified, parallel-group superiority study is to prevent and reduce the usage of Child Sexual Abuse Material (CSAM) by a Therapist Chat Service (TCS) and Selfhelp Platform for Self-Referred Patients, mostly men with a sexual interest in children. The interventions are based on Cognitive Behavioral Therapy (CBT) principles and designed to treat the sexual behavioral disorder related with CSAM consumption. 1. Participants in the Selfhelp modules group will show a statistically significantly higher proportion of reduction in CSAM behaviours four weeks after baseline, as compared to participants in the waitlist control group. 2. Participants in the Selfhelp modules followed by TCS group will show a statistically significantly higher reduction of CSAM behaviours compared to participants in the Selfhelp-only and TCS-only groups, post-intervention. Researchers will compare TCS-only-, Selfhelp-only-, Selfhelp + TCS- and Waiting group to see if if the interventions decrease CSAM use and improve mental well-being. Participants will get web based selfhelp-modules and/or text-based chat intervention operated by trained therapists.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Prevention

Currently open trials in the same condition.

NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
NCT07248280 — Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatie · Phase 3 · recruiting
NCT07382583 — Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the P · recruiting
NCT07498530 — Virtual Assistant for Exercise Adherence in Older ADULTS · NA · recruiting
NCT06682494 — Enhancing Oral Cancer Awareness · NA · recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06852443 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 7 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06852443.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing